Mylan Laboratories Limited Pantoprazole Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Pantoprazole Export Records India — #1 Exporter, 661 Shipments, $33.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pantoprazole

India Pharmaceutical Trade Intelligence

$1.3B744 Suppliers154 CountriesHS 30049039

ExportsIndia → UNITED STATES68.3%India → MALTA12.6%

ImportsGERMANY → India$152.4K BRAZIL → India$68.7K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Mylan Laboratories Limited — Pantoprazole Exporter #1 | $33.0M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Pantoprazole Exporter Profile

Indian Pharmaceutical Exporter · #1 for Pantoprazole · $33.0M export value · DGFT Verified

Mylan Laboratories Limited is the #1 Indian exporter of Pantoprazole with $33.0M in export value and 661 verified shipments. Mylan Laboratories Limited holds a 2.5% market share in Pantoprazole exports across 10 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Pantoprazole Export Profile: Buyers & Destinations

Mylan Laboratories Limited Pantoprazole export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Pantoprazole?

Country	Value	Shipments	Share
UNITED STATES	$12.4M	285	51.7%
CANADA	$4.9M	104	20.5%
HUNGARY	$4.0M	96	16.6%
NETHERLANDS	$1.4M	67	5.9%

Who Are the Top Buyers of Pantoprazole from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$5.0M	114
MYLAN PHARMACEUTICALS INC	UNITED STATES	$4.5M	109
MYLAN HUNGARY KFT,	HUNGARY	$1.8M	47
MYLAN PHARMACEUTICALS ULC,	CANADA	$1.8M	39
M/S. MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.7M	37
MYLAN PHARMACEUTICALS ULC	CANADA	$1.3M	28
MYLAN HUNGARY KFT MYLAN U	HUNGARY	$913.7K	21
MYLAN HUNGARY KFT	HUNGARY	$890.0K	20
MYLAN PHARMACEUTICALS ULC.,,	CANADA	$700.0K	14
MYLAN PHARMACEUTICALS INC.,	UNITED STATES	$600.0K	12

Mylan Laboratories Limited supplies Pantoprazole to 49 buyers globally. The largest buyer is MYLAN PHARMACEUTICALS INC, (UNITED STATES), followed by MYLAN PHARMACEUTICALS INC (UNITED STATES) and MYLAN HUNGARY KFT, (HUNGARY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Pantoprazole Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL	$4.3M	97
PANTOPRAZOLE SODIUM DELAYED RELEASE TABL	$2.7M	58
HARMLESS MEDICINES, PANTOPRAZOLE SODIUM	$454.2K	12
SANIS PANTOPRAZOLE T 40 MG 100 BT TAB PA	$350.0K	7
MYLAN PANTOPRAZOLE T 40 MG TAB 100 BT PA	$200.0K	4
PANTOPRAZOLE TAB GR 20MG EU (NO PRINT) (PACK SIZE - 44000 S BSP)	$165.6K	6
SANIS-PANTOPRAZOLE T 40 MG 100BT TAB PAC	$150.0K	3
HARMLESS MEDICINES PANTOPRAZOLE SODIUM	$150.0K	3
PANTOPRAZOLE T 40 MG 100BT TAB Packs : 100'S BOTTLE 52,816.000 PACKS	$150.0K	3
HARMLESS MEDICINES, PANTOPRAZOLE SODIUMDELAYED-RELEASE TABLETS 40 MG	$150.0K	3

Mylan Laboratories Limited exports 309 distinct Pantoprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL with 97 shipments worth $4.3M.

How Does Mylan Laboratories Limited Compare to Nearest Pantoprazole Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	AUROBINDO PHARMA LTD	$67.8M	1,356	13	$50.0K
1	MYLAN LABORATORIES LIMITED ★	$33.0M	661	10	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$31.0M	776	19	$40.0K
5	TORRENT PHARMACEUTICALS LTD	$19.7M	509	23	$38.8K

Mylan Laboratories Limited ranks #1 among 744 Indian Pantoprazole exporters. Average shipment value of $50.0K compared to the market average of $310.5K. The closest competitors by value are AUROBINDO PHARMA LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Pantoprazole Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	1,075	9.3%
SAHAR AIR	926	8.0%
SAHAR AIR CARGO ACC (INBOM4)	821	7.1%
JNPT/ NHAVA SHEVA SEA	652	5.6%
JNPT	463	4.0%
VIZAG SEA	455	3.9%
HYDERABAD AIR	435	3.7%
DELHI AIR CARGO ACC (INDEL4)	427	3.7%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Pantoprazole Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pantoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 661 individual customs records matching Mylan Laboratories Limited exporting Pantoprazole, covering 309 formulations to 10 countries via 49 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 154+ countries, 1,893+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pantoprazole

Pantoprazole

Mylan Laboratories Limited — Pantoprazole Exporter Profile

Mylan Laboratories Limited — Pantoprazole Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Pantoprazole?

Who Are the Top Buyers of Pantoprazole from Mylan Laboratories Limited?

What Is India's Total Pantoprazole Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Pantoprazole Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Pantoprazole Exporters?

What Pantoprazole Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Pantoprazole to Key Markets

United States — FDA

Canada — HC

How Does Mylan Laboratories Limited Compare to Nearest Pantoprazole Exporters?

Which Indian Ports Ship Pantoprazole Exports?

What Other Gastrointestinal Products Does Mylan Laboratories Limited Export?

Pantoprazole — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Pantoprazole Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pantoprazole Export Data from Mylan Laboratories Limited

Pantoprazole Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source